This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Deb, K. Articles by Jaiswal, Y. K Search for Related Content PubMed PubMed Citation Articles by Deb, K. Articles by Jaiswal, Y. K

A ‘minimum dose’ of lipopolysaccharide required for implantation failure: assessment of its effect on the maternal reproductive organs and interleukin-1 expression in the mouse

Molecular Biology and Reproductive Immunology Laboratory, School of Studies in Biochemistry, Jiwaji University, Gwalior- 474 011, India and ¹ Department of Zoology, Delhi University, Delhi-110007, India

Correspondence should be addressed to Kaushik Deb, D-4100, Reproductive and Developmental Biology Division, Department of Pediatrics, Medical Center North, Vanderbilt University Medical School, Nashville-37212, Tennessee, USA; Email: kaushik.deb{at}vanderbilt.edu

Genital tract infections caused by gram-negative bacteria induce abortion and are one of the most common complications of human pregnancy. This study was carried out to decipher the mechanism of gram-negative bacterial lipopolysaccharide (LPS)-induced pregnancy loss, using a mouse (Park strain) model. Since many of the biological effects of LPS are mediated by interleukin (IL)-1, the role of IL-1 in LPS-induced pregnancy loss was studied. Pregnant female animals were injected intra-peritoneally (i.p.) with different doses (1 to 50 µg) of LPS from Salmonella minnesota Re-595, on day 0.5 of pregnancy. We found that 250 µg/kg body weight (i.e. 5 µg/female mouse) of LPS when given on day 0.5 of pregnancy was the ‘minimum dose’ (MD) required to completely inhibit the implantation of the blastocyst in the mouse. The effect of this dose on the pathophysiology of the various reproductive organs (i.e. uterus, ectoplacental cones, developing fetus, ovaries etc.) was assessed on day 14 of pregnancy. The effects of this dose on the level and pattern of expression of the proinflammatory cytokine IL-1 in the maternal uterine horns and preimplantation stage embryos were studied by RT-PCR. A single dose (100 ng/mouse) of recombinant mouse IL-1 was given i.p. to pregnant females on day 1 of pregnancy to study its effect on implantation. Our results show that treatment of the pregnant animals with LPS may alter cell proliferation and induce leukocyte infiltration, degeneration of luminal glandular epithelium, and hyperplasia in the various reproductive organs, and may also alter both embryonic and uterine IL-1 expression. IL-1 administration also caused implantation failure similar to that of LPS. The observations suggest that the determined MD of LPS may alter the expression of developmentally important proinflammatory cytokines such as IL-1, which could, in turn, inhibit the normal processes of blastocyst implantation. Therefore, it is proposed that the LPS-induced histopathological alterations in the various reproductive organs of pregnant animals could be mediated by IL-1 and this may be one of the causes of failure of blastocyst implantation in the mouse.

This article has been cited by other articles:

				I. Garcia-Verdugo, D. Leiber, P. Robin, E. Billon-Denis, R. Chaby, and Z. Tanfin Direct Interaction of Surfactant Protein A with Myometrial Binding Sites: Signaling and Modulation by Bacterial Lipopolysaccharide Biol Reprod, April 1, 2007; 76(4): 681 - 691. [Abstract] [Full Text] [PDF]

				A.F. Hirschfeld, R. Jiang, W.P. Robinson, D.E. McFadden, and S.E. Turvey Toll-like receptor 4 polymorphisms and idiopathic chromosomally normal miscarriage Hum. Reprod., February 1, 2007; 22(2): 440 - 443. [Abstract] [Full Text] [PDF]